Sign in

You're signed outSign in or to get full access.

Trustees of Columbia University in the City of New York

CIK:0001420995
Endowment
$25B AUM
9 holdings
New York, NY, United States
Founded:2002
10,000 employees
Latest filing:Jun 30, 2025

The Trustees of Columbia University in the City of New York serve as the governing board of Columbia University, an Ivy League research university located in New York, NY. The institution's endowment and investment assets are managed by the Columbia Investment Management Company, a wholly owned subsidiary established in 2002. Columbia is one of the largest and most well-endowed universities in the United States, serving students, scholars, and researchers worldwide. The university and its investment office employ thousands of individuals across its academic, administrative, and investment functions.

Investment Strategy

Columbia Investment Management Company employs a diversified, long-term investment strategy across global equities, fixed income, absolute return strategies, private equity, and real assets. With a perpetual investment horizon supported by stable endowment spending rules, the firm is positioned to take advantage of illiquidity and complexity premiums in alternative assets. Oversight includes a strong focus on risk management, transparency, and socially responsible investing, guided by both internal investment professionals and the university’s Advisory Committee on Socially Responsible Investing. The firm aims to preserve and grow the University's endowment to support academic, research, and institutional priorities.

Latest 13F Filing Activity

Trustees of Columbia University in the City of New York filed their most recent 13F report on Jun 30, 2025 disclosing 9 equity positions with a total 13F market value of $691M. The fund increased holdings in SPDR S&P 500 Etf TR, Vigil Neuroscience Inc., Heico Corp. New among other positions. Trustees of Columbia University in the City of New York reduced exposure to Nu HLDGS LTD, Surrozen Inc., Rapt Therapeutics Inc. among others.

Top Buys
S
SPYSPDR S&P 500 ETF TR
+$66.9M
V
VIGLVIGIL NEUROSCIENCE INC
+$1.2M
H
HEI-AHEICO CORP NEW
+$824.6K
S
SRZNSURROZEN INC
-$130.4K
V
VORVOR BIOPHARMA INC
+$82.9K
Top Sells
N
NUNU HLDGS LTD
-$9.3M
V
VIGLVIGIL NEUROSCIENCE INC
+$1.2M
H
HEI-AHEICO CORP NEW
+$824.6K
S
SRZNSURROZEN INC
-$130.4K
R
RAPTRAPT THERAPEUTICS INC
-$89.5K

Top Holdings

S
SPYSPDR S&P 500 ETF TR
+99.5%$687.4M
V
VIGLVIGIL NEUROSCIENCE INC
+0.2%$1.5M
H
HEI-AHEICO CORP NEW
+0.1%$824.6K
S
SRZNSURROZEN INC
+0.1%$428.5K
Q
QTTBQ32 BIO INC
+0.0%$199.5K

Equity Positions (9)

TickerSecurityWeightMarket ValueSharesAvg CostPriceChange (QoQ)
SPDR S&P 500 ETF TR99.50%$687.4M1,112,613$585.27$617.85+$66.9M
VIGIL NEUROSCIENCE INC0.22%$1.5M192,973$1.70$7.95+$1.2M
HEICO CORP NEW0.12%$824.6K3,187$258.75$258.75+$824.6K
SURROZEN INC0.06%$428.5K47,930$14.35$8.94-$130.4K
Q32 BIO INC0.03%$199.5K133,903$3.44$1.49-$21.4K

Industry Allocation

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+0.2%
PHARMACEUTICAL PREPARATIONS
+0.1%